Ossica (Ibandronate Sodium Hydrate)

Ibandronate Sodium Hydrate, the active ingredient in Ossica, is a bisphosphonate presented as a oral tablet for osteoporosis treatment in postmenopausal women and men at risk of fracture. It works by inhibiting bone resorption and strengthening bone density.

GNH USA supplies Ossica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ossica is a bisphosphonate that acts on skeletal metabolism to reduce fracture risk. - Post‑menopausal osteoporosis: Improves the density of spine and femur and reduces the incidence of vertebral fractures. - Male osteoporosis: Enhances the bone mineral by reducing osteoclast activity so the risk c ​  . - Glucose   . -  . - . - . - . - . - . - . - . - . - . - . - .

Common  

{"error":"The response was incomplete incomplete."}